For the eighth consecutive year, Roche has been named as Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry of the Dow Jones Sustainability Index (DJSI). This global ranking is published annually by the S&P Dow Jones Indices and RobecoSAM and measures the sustainability performance of the world’s largest companies.
“We are very proud of this recognition,” says Severin. “Our selection once again as the world’s most sustainable healthcare company was only possible through the dedicated efforts of employees across the Group. Sustainability is an integral part of what we do at Roche and at the heart of our business, now and in the future. I strongly believe that our main contribution to society is improving healthcare, developing diagnostic tests and medicines to meet some of the most urgent medical needs. If we are successful in exactly doing this, we will have a long and lasting impact”.
Recognised for commitment towards access to healthcare and a culture of team-work and collaboration
Roche performed particularly well across a number of categories and DJSI noted “Roche has maintained its leadership in the pharmaceuticals sector through its excellent sustainability strategy, which is fully embedded in the company’s business and culture. By placing focus on access to healthcare, compliance and transparency, diverse work culture and collaborating with diverse partners, Roche is committed to creating value for all of its stakeholders.”
The global ranking is published annually by the S&P Dow Jones Indices and RobecoSAM and measures the performance of the world’s sustainability leaders. RobecoSAM invites 3,450 publicly traded companies to participate. Companies are selected for the indices according to a systematic Corporate Sustainability Assessment (CSA) performed by RobecoSAM.
Only firms that lead their industries based on this assessment are included in the indices. This is determined by a comprehensive assessment of long-term economic, environmental and social criteria that account for general as well as industry-specific sustainability trends. Each company reports on an online questionnaire including over 100 qualitative and quantitative questions, supported by extensive documentation, complemented by examination of media coverage, stakeholder commentaries and other publicly available sources.
The UN Sustainable Development Goals (SDGs)
This year has also marked Roche’s first steps in direct response to the United Nations General Assembly’s unanimous adoption of 17 Sustainable Development Goals (SDGs). Roche is committed to supporting a number of the SDGs in line with its business strategy; in particular, SDG3 “ensure healthy lives and promote well-being for all”.
Learn more about Roche’s commitment to sustainability.